Similar articles

• Revisiting cardiac injury during acute heart failure: further characterization and a possible target for therapy.

  Collins SP, Pang PS, Butler J, Fonarow G, Metra M, Gheorghiade M. Collins SP, et al. Am J Cardiol. 2015 Jan 1;115(1):141-6. doi: 10.1016/j.amjcard.2014.09.040. Epub 2014 Oct 13. Am J Cardiol. 2015. PMID: 25456864 No abstract available.
• Heart failure in pregnancy: an overview.

  Ahmad WA, Khanom M, Yaakob ZH. Ahmad WA, et al. Int J Clin Pract. 2011 Aug;65(8):848-51. doi: 10.1111/j.1742-1241.2011.02714.x. Int J Clin Pract. 2011. PMID: 21762308 Review.
• A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics.

  Ruiz-Esparza GU, Segura-Ibarra V, Cordero-Reyes AM, Youker KA, Serda RE, Cruz-Solbes AS, Amione-Guerra J, Yokoi K, Kirui DK, Cara FE, Paez-Mayorga J, Flores-Arredondo JH, Guerrero-Beltrán CE, Garcia-Rivas G, Ferrari M, Blanco E, Torre-Amione G. Ruiz-Esparza GU, et al. Eur J Heart Fail. 2016 Feb;18(2):169-78. doi: 10.1002/ejhf.463. Epub 2016 Jan 7. Eur J Heart Fail. 2016. PMID: 26749465 Free PMC article.
• [Physiopathological basis of the treatment of heart failure].

  Vinsonneau C, Su JB, Benacerraf S, Darmon ME, Duval-Moulin AM, Crozatier B, Dubois-Randé JL, Castaigne A, Hittinger L. Vinsonneau C, et al. Arch Mal Coeur Vaiss. 1998 Nov;91(11):1315-24. Arch Mal Coeur Vaiss. 1998. PMID: 9864599 French.
• Advanced research on the microRNA mechanism in heart failure.

  Deng J, Zhong Q. Deng J, et al. Int J Cardiol. 2016 Oct 1;220:61-4. doi: 10.1016/j.ijcard.2016.06.185. Epub 2016 Jun 26. Int J Cardiol. 2016. PMID: 27372044 Review.